Evidence map›Paper›PMID 25995477›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Opposing role for Egr3 in nucleus accumbens cell subtypes in cocaine action.

Ramesh Chandra, T Chase Francis, Prasad Konkalmatt, Ariunzaya Amgalan, Amy M Gancarz, David M Dietz, Mary Kay Lobo

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 135 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Changes in nucleus accumbens core translatome accompanying incubation of cocaine craving.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ramesh ChandraDepartment of Anatomy and Neurobiology and.
T Chase FrancisDepartment of Anatomy and Neurobiology and.
Prasad KonkalmattDepartment of Medicine, Division of Nephrology, University of Maryland School of Medicine Baltimore, Maryland 21201, and.
Ariunzaya AmgalanDepartment of Anatomy and Neurobiology and.
Amy M GancarzDepartment of Pharmacology and Toxicology, The Research Institution Addictions, State University of New York at Buffalo, Buffalo, New York 14214.
David M DietzDepartment of Pharmacology and Toxicology, The Research Institution Addictions, State University of New York at Buffalo, Buffalo, New York 14214.
Mary Kay LoboDepartment of Anatomy and Neurobiology and mklobo@som.umaryland.edu.
University at Buffalo, State University of New York · USInstitute of Neurobiology · BGUniversity of Maryland, Baltimore · US

Funding

RESEARCH TRAINING ON ALCOHOL ETIOLOGY AND TREATMENTT32AA007583 · NIAAA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Gregory G Homish, KENNETH E LEONARD · 2000 to 2026
$8.5M
RENAL DOPAMINE-1 RECEPTOR DEFECT IN HYPERTENSIONR01DK039308 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI JOSE, PEDRO A. · 1987 to 2020
$7.4M
Cocaine-induced mitochondrial mechanisms and molecular mediators in reward circuitryR01DA038613 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI LOBO, MARY KAY · 2014 to 2025
$4.9M
Cocaine-induced neuroplasticity: a new role for TGF beta signalingR01DA037257 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DIETZ, DAVID M · 2014 to 2018
$2.1M
Role of Dopamine D2 Receptor in Renal Inflammation and InjuryR01DK090918 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI ARMANDO, INES · 2011 to 2015
$1.7M
NIAAA NIH HHS T-32-AA007583NIAAA NIH HHS T32 AA007583NIDA NIH HHS R01 DA037257NIDA NIH HHS R01DA037257NIDA NIH HHS R01 DA038613NIDA NIH HHS R01DA038613NIDDK NIH HHS R01 DK039308NIDDK NIH HHS R01DK039308NIDDK NIH HHS R01 DK090918NIDDK NIH HHS R01DK090918
6 · The paper itself

Abstract

An imbalance in molecular signaling cascades and transcriptional regulation in nucleus accumbens (NAc) medium spiny neuron (MSN) subtypes, those enriched in dopamine D1 versus D2 receptors, is implicated in the behavioral responses to psychostimulants. To provide further insight into the molecular mechanisms occurring in MSN subtypes by cocaine, we examined the transcription factor early growth response 3 (Egr3). We evaluated Egr3 because it is a target of critical cocaine-mediated signaling pathways and because Egr3-binding sites are found on promoters of key cocaine-associated molecules. We first used a RiboTag approach to obtain ribosome-associated transcriptomes from each MSN subtype and found that repeated cocaine administration induced Egr3 ribosome-associated mRNA in NAc D1-MSNs while reducing Egr3 in D2-MSNs. Using Cre-inducible adeno-associated viruses combined with D1-Cre and D2-Cre mouse lines, we observed that Egr3 overexpression in D1-MSNs enhances rewarding and locomotor responses to cocaine, whereas overexpression in D2-MSNs blunts these behaviors. miRNA knock-down of Egr3 in MSN subtypes produced opposite behavioral responses from those observed with overexpression. Finally, we found that repeated cocaine administration altered Egr3 binding to promoters of genes that are important for cocaine-mediated cellular and behavioral plasticity. Genes with increased Egr3 binding to promoters, Camk2α, CREB, FosB, Nr4a2, and Sirt1, displayed increased mRNA in D1-MSNs and, in some cases, a reduction in D2-MSNs. Histone and the DNA methylation enzymes G9a and Dnmt3a displayed reduced Egr3 binding to their promoters and reduced mRNA in D1-MSNs. Our study provides novel insight into an opposing role of Egr3 in select NAc MSN subtypes in cocaine action.

Indexed as

Amino Acid SequenceAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Cell LineCocaine-Related DisordersCyclic AMP Response Element-Binding ProteinDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3AEarly Growth Response Protein 3Histone-Lysine N-MethyltransferaseMaleMiceMice, Inbred C57BLMolecular Sequence DataNeuronsNuclear Receptor Subfamily 4, Group A, Member 2Calcium-Calmodulin-Dependent Protein Kinase Type 2Camk2a protein, mouseCreb1 protein, mouseCyclic AMP Response Element-Binding ProteinDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADnmt3a protein, mouseEarly Growth Response Protein 3Egr3 protein, mouseG9a protein, mouseHistone-Lysine N-MethyltransferaseNr4a2 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 2Proto-Oncogene Proteins c-fosReceptors, Dopamine D1Receptors, Dopamine D2Sirt1 protein, mouseSirtuin 1cocaineEgr3medium spiny neuronsnucleus accumbensRiboTagtranscription

Identifiers

PMID25995477
PMCPMC4438133
OpenAlexW1845678325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.